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Cancer, a complex disease that places a significant burden on indivi­
duals, families, health services and society, is emerging as a critical 
public health problem in South Africa (SA).[1] Based on the most recent 
South African National Cancer Registry data, 1 in 9 women and 1 in 8 
men are at risk of developing cancer in their life time.[2] The most 
commonly diagnosed cancers among women are those of the breast, 
cervix, colorectum and uterus and Kaposi’s sarcoma, which together 
account for half of all female cancers. Among men the commonest 
cancers are those of the prostate, lung, colorectum and oesophagus 
and Kaposi’s sarcoma, which together total 36% of all cancers in 
men. In SA, as elsewhere in Africa, the majority of patients present 
with late­stage disease, which is associated with poor outcomes.[3,4] 
Worryingly, the proportion of all deaths attributed to cancer in SA 
has increased steadily over the past few years, from 7.3% in 2011 to 
7.8% in 2012 and 8.3% in 2013.[5] Of additional concern is the forecast 
that the number of new cancer cases is expected to increase by 46% by 
2030.[6] Unless addressed, the rising burden of cancer could counteract 
the gains made from the stabilising communicable disease rates in SA 
and increasing life expectancy.[7] Research directed at understanding 
the epidemiology and distinct features of cancer in SA, such as factors 
associated with late stage at presentation and cost­effective early 
detection strategies, is crucial in addressing the cancer burden.
Cognisant of the growing burden of cancer in SA, the Minister of 
Health, Dr Aaron Motsoaledi, approved the establishment of the 
Ministerial Advisory Committee on the Prevention and Control of 
Cancer (MACC) in accordance with section 91(1) of the National 
Health Act 61 of 2003.[8] The purpose of the MACC is to advise 
the Minister on all matters related to national cancer prevention 
and control. Recognising the importance of research in identifying, 
prioritising and addressing the cancer burden, the Committee tasked 
its research working group to review the current cancer research 
landscape in SA.
Methods
A cross­sectional survey was conducted between September 2014 and 
June 2015. The National Department of Health, through the office of 
the Director­General of Health, formally contacted 29 institutions (all 
23 higher academic institutions and six institutions either conducting 
or funding health research in SA) via email requesting information 
on the titles of all current (2014) and recently completed (2013/2014) 
cancer research projects. Three reminder emails were subsequently 
sent to non­responding institutions. Information was entered into an 
Excel database and duplicate projects were removed. Three members 
of the MACC research working group used the project titles to 
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Background and objectives. Cancer is emerging as a critical public health problem in South Africa (SA). Recognising the importance of 
research in addressing the cancer burden, the Ministerial Advisory Committee on the Prevention and Control of Cancer (MACC) research 
working group undertook a review of the current cancer research landscape in SA and related this to the cancer burden.
Methods. Academic and research institutions in SA were contacted to provide information on the titles of all current and recently completed 
(2013/2014) cancer research projects. Three MACC research working group members used the project titles to independently classify the 
projects by type of research (basic, clinical and public health – projects could be classified in more than one category) and disease site. 
A more detailed classification of projects addressing the five most common cancers diagnosed in males and females in SA was conducted 
using an adapted Common Scientific Outline (CSO) categorisation.
Results. Information was available on 556 cancer research projects. Overall, 301 projects were classified as clinical, 254 as basic science and 
71 as public health research. The most common cancers being researched were cancers of the breast (n=95 projects) and cervix (n=43), 
leukaemia (n=36), non­Hodgkin’s lymphoma (n=35) and lung cancer (n=23). Classification of the five most common cancers in males and 
females in SA, using the adapted CSO categories, showed that the majority of projects related to treatment, with relatively few projects on 
prevention, survivorship and patient perspectives.
Conclusion. Our findings established that there is a dearth of public health cancer research in SA.
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independently classify research projects by: 
(i) disease site using the International Cancer 
Research Partnership classification;[9] and (ii) 
scientific domain (basic, clinical and public 
health research). Project titles suggesting that 
the research was aimed at understanding 
fundamental biological systems were 
classified as basic science research; those 
suggesting that the research was conducted 
with human subjects or on material of human 
origin such as tissues, and for which it was 
likely that an investigator directly interacted 
with human subjects, were classified as 
clinical research; and research conducted at a 
population or organisational level, including 
health system research, environmental and 
occupational research or patient perspectives, 
was classified as public health research. 
Projects could be classified into more than one 
scientific domain. A more detailed analysis 
was conducted for the five most common 
male and female cancers diagnosed in SA, 
using an adaption of the Common Scientific 
Outline (CSO) classification system. [10] The 
CSO classification is organised around six 
broad areas of scientific interest in cancer 
research, viz.: (i)  biology; (ii) aetiology; 
(iii)  prevention; (iv) early detection, diag­
nosis, and prognosis; (v) treatment; and 
(vi)  cancer control, survivorship, and out­
comes research, and is used to discuss, 
compare and present cancer research 
portfolios. For our analysis we expanded the 
CSO categories into nine categories to provide 
more detail. The expanded adapted CSO 
categories were: (i)  biology; (ii) aetiology; 
(iii) prevention; (iv) early detection and 
diagnosis; (v) clinical prognosis/progression; 
(vi) treatment; (vii)  clinical audits; (viii) 
survivor ship; and (ix) patient perspectives. 
Research activity in the five most commonly 
diagnosed male and female cancers in SA 
was assessed. The most common cancers 
were identified using cancer incidence data 
from the SA National Cancer Registry.[2]
Results
Fifteen of the 29 institutions (52%) res­
ponded directly, and infor mation on an 
additional six institutions was obtained 
indirectly through responses from three SA 
organisations that fund cancer research, viz. 
the South African Medical Research Council, 
the National Research Foundation and the 
Cancer Association of South Africa. In total, 
these institutions provided information on 
757 projects. Projects that were completed 
before 2013 (n=110), duplicate projects 
submitted by both research funding agencies 
and recipient institutions (n=38) and non­
research projects (n=53) were removed, 
leaving a total of 556 projects for analysis.
Scientific domain and disease site
Overall, 301 projects were classified as clini­
cal, 254 as basic science and 71 as public 
health research (Fig. 1). The majority of 
projects (n=392) focused on a single disease 
site, 18 projects addressed multiple sites 
and 146 were non­site­specific. The five 
most common cancers being researched 
were cancers of the breast (n=95 projects) 
and cervix (n=43), leukaemia (n=36), non­
Hodgkin’s lymphoma (n=35) and lung 
cancer (n=23). There were 29 paediatric 
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Fig. 1. Cancer projects classified by type of research domain (note: research projects could be categorised 
in more than one research domain).
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Fig. 2. Projects addressing the most commonly diagnosed female cancers in SA (note: research projects 
could be categorised in more than one research domain).
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cancer projects, with the vast majority (n=24) classified as addressing 
clinical research. The majority of site­specific paediatric cancer 
research projects were on leukaemia (n=4) and lymphomas (n=4). 
The 556 projects included 95 clinical trials, with 64 being phase III 
clinical trials. The majority of clinical trials were related to breast 
cancer (n=22), leukaemia (n=15) and lung cancer (n=14). There were 
no costing or cost­effectiveness studies.
Research on the most common cancers  
diagnosed in SA
A total of 164 projects addressed the five most common cancers 
diagnosed in women in SA (Fig. 2). Overall, clinical research was the 
most common type of research being conducted and public health 
research the least common. In contrast, for cervical cancer there 
were a similar number of research projects across all three scientific 
domains (i.e. basic science, clinical and public health). Classification 
using the adapted CSO categories (Table 1) showed that the majority 
of projects were related to treatment, with relatively few projects on 
survivorship and patient behaviour.
A total of 72 projects addressed the five most common cancers in 
males (Fig. 3). The majority of the projects were related to clinical 
research (n=42), with relatively few (n=7) addressing public health 
issues. Projects on lung cancer dominated, and according to CSO 
categorisation (Table 1) the majority of these were treatment­related 
projects. There were no projects being conducted on survivorship, 
and there was one project on prevention of cancer and two projects 
addressing patient perspectives.
Discussion
In an effort to understand whether current research addresses 
the burden of cancer in SA, academic and research organisations 
in the country were contacted for information on current and 
recently completed cancer research. Our findings established 
that there is a dearth of public health research. In a resource­
limited setting such as SA, public health cancer research offers 
many opportunities to address the cancer burden. For example, 
research that identifies reasons for late presentation, supports 
early diagnosis, identifies cost­effective management, improves the 
efficiency and effectiveness of cancer management and improves the 
quality of life of individuals with cancer will be particularly useful 
in informing local cancer policies and guidelines. It is of concern 
that there were no costing or cost­effectiveness cancer research 
projects. However, it is possible that desk­based economic studies 
that did not require ethical approval could inadvertently have been 
excluded from the list of projects submitted by institutions. In 
the SA context, economic studies could be invaluable in guiding 
diagnosis, treatment and prevention options as well as decisions on 
resource allocation. Public health cancer research could be limited 
as a result of lack of requisite research skills and/or limited funding 
for such research. This needs further investigation. Previous reports 
have highlighted the mismatch between the disease burden in 
developing countries and the human capacity to generate relevant 
new knowledge,[11,12] and there have been calls to strengthen 
the health research capacity in the country. It is important that 
initiatives aimed at increasing research capacity are directed at 
priority health problems such as cancer, and that the gap in public 
health cancer research is addressed.
Breast cancer is the most common cancer diagnosed in women 
in SA, with an age­standardised incidence rate of 27 per 100 000; 
however, in several regions in the country cervical cancer remains 
the most common cancer.[2] It is encouraging that current research 
on female cancers focuses on the two most common cancers 
Table 1. CSO classification for research projects addressing the five most commonly diagnosed cancers in SA
  Biology Aetiology Prevention
Early 
detection 
and 
diagnosis
Clinical 
prognosis/ 
progression/
staging Treatment
Patient 
profiles, 
clinical audits 
and review Survivorship
Patient 
perspectives Total
Top five cancers 
in females
                   
Breast 12 18 2 9 14 35 3 2 0 95
Cervical 5 4 13 2 6 8 3 0 1 42*
Colorectal 3 2 0 0 0 3 4 0 0 12*
Uterus 1 0 0 2 0 0 1 0 3 7
 Kaposi’s 
sarcoma
2 1 0 0 2 0 1 0 0 6
Total 23 25 15 13 22 46 12 2 4 162
Top five cancers 
in males
                   
Prostate 1 0 0 4 0 8 0 0 1 14
Lung 1 2 1 1 1 16 0 0 1 23
Colorectal 3 2 0 0 0 3 4 0 0 12*
Oesophageal 4 4 0 0 2 6 0 0 0 16
 Kaposi’s 
sarcoma
2 1 0 0 2 0 1 0 0 6
Total 11 9 1 5 5 33 5 0 2 71
*One project title too vague to classify.
RESEARCH
610       June 2016, Vol. 106, No. 6
diagnosed in the country, viz. breast and cervical cancer. Further 
research on prevention, patient perspectives and survivorship 
is required. Overall, current research is skewed towards cancers 
most common in females as opposed to those most common in 
males. Relative to the burden of cancer in SA, limited research 
is being done on prostate cancer, colorectal cancer and Kaposi’s 
sarcoma.
Study limitations
There were several limitations in our approach to determining 
current cancer research, and the results need to be interpreted 
with this in mind. Firstly, only 52% of institutions contacted 
responded. However, the institutions in SA known to have a high 
research influence did provide information on their cancer research 
portfolios.[13] Although each project was classified by more than 
one team member, information on project aims and objectives was 
unavailable, so classification by scientific domain and the expanded 
CSO categories was challenging and subject to misclassification. 
This review did not assess the quality of the research or review 
past cancer research. Further discussions on the challenges faced 
by local cancer researchers and funding agencies, the influence of 
local research on policies and guidelines and the extent to which 
research addresses the specific needs of the country are required to 
understand the SA cancer research landscape fully. The SA Medical 
Research Council is well placed to facilitate such discussions and 
future assessments.
Conclusion
Research is key to addressing the cancer burden in SA. This review 
highlighted the need for a cancer research registry that will provide 
ongoing information on the state of cancer research in the country, 
enable assessment of the relevance of such research, and assist in 
identifying research and funding priorities.
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